BR9707713A - Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios. - Google Patents

Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios.

Info

Publication number
BR9707713A
BR9707713A BR9707713-5A BR9707713A BR9707713A BR 9707713 A BR9707713 A BR 9707713A BR 9707713 A BR9707713 A BR 9707713A BR 9707713 A BR9707713 A BR 9707713A
Authority
BR
Brazil
Prior art keywords
composition
lipids
reduce
food supplement
soy
Prior art date
Application number
BR9707713-5A
Other languages
English (en)
Inventor
Lars Henrik Hoie
Original Assignee
Nutri Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8091163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9707713(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutri Pharma As filed Critical Nutri Pharma As
Publication of BR9707713A publication Critical patent/BR9707713A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Confectionery (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO E SUA UTILIZAçãO COMO UM SUPLEMENTO ALIMENTAR OU PARA REDUZIR O NìVEL PLASMáTICO DE LIPìDIOS"<D>. Uma composição com base em ingredientes de soja compreende: (a) proteína de soja isolada, (b) fibras de soja e opcionalmente uma fonte adicional de proteínas, uma fonte de carboidratos, agentes aromatizantes, vitaminas, minerais, eletrólitos, elementos traço e outros aditivos convencionais, a quantidade de (a) sento tal que o teor de proteína proporcione pelo menos 15% de teor de energia total da composição e a proporção em peso entre (a) e (b) sendo de pelo menos 2. A composição é útil como uma dieta parcial ou total para pessoas com peso excessivo ou obesas e é também útil para reduzir o teor de colesterol e o teor de triglicerídios e para elevar a proporção plasmática entre os colesteróis HDL/LDL.
BR9707713-5A 1996-02-29 1997-02-12 Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios. BR9707713A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK22796 1996-02-29
PCT/IB1997/000152 WO1997031546A1 (en) 1996-02-29 1997-02-12 Composition and its use as a food supplement or for lowering lipids in serum

Publications (1)

Publication Number Publication Date
BR9707713A true BR9707713A (pt) 2000-01-04

Family

ID=8091163

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707713-5A BR9707713A (pt) 1996-02-29 1997-02-12 Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios.

Country Status (25)

Country Link
US (2) US6136367A (pt)
EP (1) EP0902624B1 (pt)
JP (1) JP3545423B2 (pt)
KR (1) KR19990087376A (pt)
CN (1) CN1104855C (pt)
AT (1) ATE198405T1 (pt)
AU (1) AU715424B2 (pt)
BR (1) BR9707713A (pt)
CA (1) CA2247138A1 (pt)
CZ (1) CZ265698A3 (pt)
DE (2) DE69703839T2 (pt)
DK (1) DK0902624T3 (pt)
EA (1) EA000821B1 (pt)
ES (1) ES2149140T3 (pt)
GR (1) GR3035302T3 (pt)
HK (1) HK1016842A1 (pt)
HU (1) HUP9902145A3 (pt)
IL (1) IL125729A (pt)
NO (1) NO314875B1 (pt)
NZ (1) NZ331507A (pt)
PL (1) PL184852B1 (pt)
PT (1) PT902624E (pt)
TR (1) TR199801709T2 (pt)
UA (1) UA63901C2 (pt)
WO (1) WO1997031546A1 (pt)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2337933A (en) * 1998-06-04 1999-12-08 Stephen Bloor Treating or prophylaxis of smoking related diseases
US6150399A (en) 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
WO2000021391A1 (en) * 1998-10-09 2000-04-20 Sanacare Aps Diet food
EP1133307B1 (en) * 1998-11-25 2003-06-11 Nutri Pharma ASA Use of a composition comprising soy protein, dietary fibres and a phytoestrogen compound in the prevention and/or treatment of pulmonary diseases
US6630178B1 (en) 1998-11-25 2003-10-07 Nutri Pharma Asa Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
US6241996B1 (en) 1999-04-09 2001-06-05 Novartis Nutrition Ag Liquid soy nutritional products
US6355295B1 (en) 2000-02-29 2002-03-12 Protein Technologies International, Inc. Soy functional food ingredient
US6465037B1 (en) 2000-02-29 2002-10-15 Protein Technologies International, Inc. Process for producing a novel soy functional food ingredient
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US7118873B2 (en) 2000-12-12 2006-10-10 The University Of Connecticut Polynucleotides encoding cellular transporters and methods of use thereof
US20030082647A1 (en) * 2000-12-12 2003-05-01 Reenan Robert A. Transporter protein
DE60218822T2 (de) * 2001-02-09 2007-07-12 Unilever N.V. Nahrungsmittel enthaltend sojaprotein und statin
US6582746B2 (en) 2001-02-28 2003-06-24 Solae, Llp Meat product
US6355296B1 (en) 2001-02-28 2002-03-12 Protein Technologies International, Inc. Functional food ingredient
US6423364B1 (en) 2001-02-28 2002-07-23 Protein Technologies International, Inc. Functional food ingredient
US20040234631A1 (en) * 2001-07-03 2004-11-25 Hoie Lars Henrik Composition comprising soy and use thereof in the provention and/or treatment of various diseases
US20030104033A1 (en) * 2001-07-13 2003-06-05 Lai Chon-Si Enteral formulations
US20030170371A1 (en) * 2002-01-10 2003-09-11 Cargill, Inc. High fat/fiber composition
WO2003070018A2 (en) * 2002-02-22 2003-08-28 Nutri Pharma Asa Food products comprising soy protein
NZ536466A (en) * 2002-04-18 2008-04-30 Monsanto Technology Llc Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
US20030211207A1 (en) * 2002-05-07 2003-11-13 Newman Michael D. Apparatus and method for providing treatment to a continuous supply of food product using a vacuum process
DE10303900A1 (de) * 2003-01-31 2004-08-12 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend Levane
US20040022877A1 (en) * 2002-07-30 2004-02-05 Nancy Green Cardiovascular health enhancement with soy fortified orange juice compositions
US20040022876A1 (en) * 2002-07-30 2004-02-05 Nancy Green Cardiovascular health enhancement with soy fortified citrus juice compositions
WO2004020977A2 (en) * 2002-08-29 2004-03-11 University Of Massachusetts Utilization of emulsion interface engineering to produce oxidatively stable lipid delivery systems
MXPA05002095A (es) * 2002-09-03 2005-06-06 Biovail Lab Int Srl Formulaciones farmaceuticas de pravastatina y metodos de su uso.
KR20040035504A (ko) * 2002-10-22 2004-04-29 이환업 해독, 항산화 기능 작용, 흡연 억제 기능 작용을 하는바이오 복합 단백질 조성방법
KR100515923B1 (ko) * 2002-10-22 2005-09-21 이환업 바이오 복합 단백질 조성방법
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
AU2003297568A1 (en) * 2002-11-22 2004-06-18 Shaklee Corporation Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass
US20040258825A1 (en) * 2003-06-17 2004-12-23 Ndife Louis I. Nutritional compositions containing spray dried fiber
US20050186306A1 (en) * 2004-02-19 2005-08-25 Susanne Sonneveld Low carbohydrate cereal-like food product
US20060024391A1 (en) * 2004-07-30 2006-02-02 Lak Zarahmehran S Dietary nutritional suppliments for persons smoking tobacco products
US20060088639A1 (en) * 2004-10-25 2006-04-27 Lewis Karen M Food additive, baked food composition and method for lowering blood cholesterol
KR100667038B1 (ko) * 2004-12-15 2007-01-12 인하대학교 산학협력단 고지혈증 및 복부비만을 예방하는 마늘, 대두단백 및 타우린을 유효성분으로 함유하는 혼합 조성물
CN101166425A (zh) * 2005-03-09 2008-04-23 卡吉尔股份有限公司 大豆子叶纤维和生产所述纤维的方法
ES2281270B1 (es) 2005-11-30 2008-07-01 La Morella Nuts, S.A. Alimento funcional con efectos positivos en la prevencion de enfermedades cardiovasculares.
US20070202215A1 (en) * 2006-02-28 2007-08-30 Zahramehran Salari Lak Dietary nutritional supplements for persons consuming alcohol products
US20070207226A1 (en) * 2006-03-03 2007-09-06 Mowrey Daniel B Composition for enhancing muscle mass development in animals
EP2060263A4 (en) * 2006-08-21 2012-01-25 Calpis Co Ltd AGENT FOR IMPROVING LIPID METABOLISM
JP2009034018A (ja) * 2007-07-31 2009-02-19 Ajinomoto Co Inc トマト風味栄養組成物
CZ302771B6 (cs) * 2007-10-11 2011-11-02 Adler Wellness Produkte, S.R.O. Potravinárská proteinová smes a zpusob její výroby
MX2007014944A (es) * 2007-11-28 2009-05-28 Kyu Il Lee Composicion de extractos de soya, arroz, ajonjoli y tuna para suplemento alimenticio.
KR101876471B1 (ko) * 2009-05-26 2018-07-16 (주)아모레퍼시픽 콩 추출물을 함유하는 혈액 순환 개선 및 혈관 건강 증진용 조성물
WO2011146442A1 (en) * 2010-05-18 2011-11-24 Abbott Laboratories Ultrasonically-treated nutritional products having extended shelf life
US8685918B1 (en) * 2011-01-05 2014-04-01 Marco Gasparotti Weight loss regimen comprising enteral and oral feeding segments effective for the treatment of obesity
CA2942555A1 (en) 2014-03-26 2015-10-01 Abbott Laboratories Nutritional supplement powder
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
RU2612776C1 (ru) * 2015-12-04 2017-03-13 Общество с ограниченной ответственностью "РЕБОРН" Концентрат для вегетарианского и диетического питания
CN108697139A (zh) 2016-02-29 2018-10-23 雅培制药有限公司 营养补充粉
CN106729616A (zh) * 2016-12-05 2017-05-31 郑州诚合信息技术有限公司 一种用于治疗肥胖症的西药组合物
CN106729600A (zh) * 2016-12-05 2017-05-31 郑州诚合信息技术有限公司 一种用于肥胖症的西药组合物
WO2021064107A1 (en) 2019-10-02 2021-04-08 Norvia Nutrition Ltd. Composition comprising soy and use thereof in the prevention and/or treatment of microvascular or lipoprotein related diseases, microcardiovascular diseases, atherosclerosis, hypertension, and in patients with such cardiovascular disorders suffering from alzheimer and dementia, overweight and obesity, type 2 diabetes, asthma and other disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product

Also Published As

Publication number Publication date
AU715424B2 (en) 2000-02-03
DE69703839D1 (de) 2001-02-08
IL125729A (en) 2001-09-13
US6268011B1 (en) 2001-07-31
NZ331507A (en) 1999-03-29
NO983971D0 (no) 1998-08-28
PL328634A1 (en) 1999-02-15
ES2149140T1 (es) 2000-11-01
EA000821B1 (ru) 2000-04-24
EA199800779A1 (ru) 1999-02-25
DE69703839T2 (de) 2001-05-31
KR19990087376A (ko) 1999-12-27
HK1016842A1 (en) 1999-11-12
DE902624T1 (de) 2000-11-02
CN1212605A (zh) 1999-03-31
PL184852B1 (pl) 2002-12-31
DK0902624T3 (da) 2001-05-21
HUP9902145A3 (en) 2000-04-28
UA63901C2 (en) 2004-02-16
PT902624E (pt) 2001-04-30
US6136367A (en) 2000-10-24
CN1104855C (zh) 2003-04-09
ATE198405T1 (de) 2001-01-15
ES2149140T3 (es) 2001-04-16
WO1997031546A1 (en) 1997-09-04
GR3035302T3 (en) 2001-04-30
CZ265698A3 (cs) 1998-12-16
TR199801709T2 (xx) 1998-12-21
NO983971L (no) 1998-10-28
CA2247138A1 (en) 1997-09-04
JP3545423B2 (ja) 2004-07-21
HUP9902145A2 (hu) 1999-11-29
NO314875B1 (no) 2003-06-10
EP0902624B1 (en) 2001-01-03
EP0902624A1 (en) 1999-03-24
JP2000505308A (ja) 2000-05-09
IL125729A0 (en) 1999-04-11
AU1615397A (en) 1997-09-16

Similar Documents

Publication Publication Date Title
BR9707713A (pt) Composição e sua utilização como umm suplemento alimentar ou para reduzir o nìvel plasmático de lipìdios.
BR9815302A (pt) Método para diminuir a concentração de colesterol ldl e aumentar a concentração de colesterol hdl no sangue para reduzir o risco de aterosclerose e doença vascular
Antoniades et al. Oxidative stress, antioxidant vitamins, and atherosclerosis
BRPI0513500B8 (pt) uso de equivalentes de aspartato e composição nutricional ou farmacêutica
Mattson et al. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man.
Washburn et al. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women
Luoma et al. High serum alpha‐tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland
Hagey et al. Role of exercise and nutrition in menopause
WO2002080860A3 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
DE69916414D1 (de) Sojazubereitungen und deren verwendung zur gesundheitsförderung
BR9714117A (pt) Processo para preparar condimentos de alimento, ingrediente de alimento e composições de item de alimento, condimento e seu uso
BR0207948A (pt) Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
BR9808948A (pt) Composição de confeitaria
ATE293367T1 (de) Nahrungszusammensetzungen enthaltend methionin
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
BR0209245A (pt) Uso de proteìna e aminoácidos essenciais para tratar emenorréia e distúrbios afins
BR9910359A (pt) Proteìna hìbrida para inibição de desgranulação de mastócitos e seu uso
Duell et al. The relationship between sex hormones and high-density lipoprotein cholesterol levels in healthy adult men
AR039118A1 (es) Barra alimenticia para mantener el estado de alerta
Bulló et al. Dietary vitamin K intake is associated with bone quantitative ultrasound measurements but not with bone peripheral biochemical markers in elderly men and women
Phinney et al. The transient hypercholesterolemia of major weight loss
Molina-Pérez et al. Relative and combined effects of ethanol and protein deficiency on bone histology and mineral metabolism
BRPI0417251A (pt) composição comestìvel, métodos de controle do peso corporal de um animal, de reduzir a ingestão de ração e o peso do corpo de um animal com excesso de peso e obeso, de manter o peso de um animal, de aumentar a ingestão de alimento e o peso corporal de um animal com peso abaixo do normal, e, suplemento para animais, petisco para animais ou refeição para animais
AR046772A1 (es) Medicamento que comprende ptx3, solo o en combinacion con tsg-6, para tratar enfermedades degenerativas de cartilago y hueso y tratar la infertilidad femenina
Davies et al. Determinants of endogenous calcium entry into the gut

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: O DEPOSITANTE DEIXOU DE APRESENTAR MANIFESTACAO SOBRE O PARECER NEGATIVO, ASSIM, DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR.

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/21 (2016.01), A23L 33/185 (2016.0